Q1 FY27 results analysis · August 12, 2026
Abbott India Ltd (ABBOTINDIA) Q1 FY27 Results Analysis: PAT Jumps 17%, Revenue Lags Industry
+17.1%PAT year on year, Rs. 428.52 Cr
Quick summary
Abbott India Ltd's Q1 FY27 numbers came in mixed, with revenue of Rs. 1,813.68 Cr (+4.33% YoY) and PAT growth of +17.13% YoY. Here's a quick read of what worked, what to watch, and what management said.
Quick Details
| Results date | August 12, 2026 |
|---|---|
| Quarter | Q1 FY 2026-2027 |
| Revenue (Q1) | Rs. 1,813.68 Cr (+4.33% YoY) |
| PAT (Q1) | Rs. 428.52 Cr (+17.13% YoY) |
| EBITDA margin | 32.96% (+314 bps YoY) |
| EPS (Q1) | Rs. 201.66 (+17.13% YoY) |
| Market cap | Rs. 59,821.41 Cr |
| CMP | Rs. 28,140.00 |
Quarter Snapshot
Revenue growth decelerated to 4.33% YoY, lagging industry growth, but PAT grew 17% due to operating leverage and cost controls. EBITDA margin expanded 314bps YoY, partly from a temporary inventory-FX benefit expected to reverse. Weak top-line performance relative to peers is a concern.
Key Investment Insights
Key Positives
- Revenue grew 4.33% YoY to Rs.1,813.68 Cr.
- PAT grew 17.13% YoY to Rs.428.52 Cr.
- EBITDA margin expanded 314 bps YoY to 32.96%.
- Employee cost growth slowed to 4.30% YoY from 13.8% in FY26.
- Inventory build reduced to Rs.31.10 Cr from Rs.72.85 Cr YoY.
Risk Factors
- Revenue growth decelerated to 4.33% YoY, below FY26's 8.1% and below IPM estimate of ~11.3%, indicating possible market share loss.
- EBITDA margin expansion of 314 bps was partly driven by temporary inventory-FX benefit; purchases ratio expected to revert to 48-50% as old stock is replaced.
Ask about this
Ask Cofacto a question about this result. Answers cite filings and company data.
Companies on this page
Related
Disclaimer: This results analysis is published for educational and informational purposes only. It is not investment advice, not a recommendation to buy, sell or hold any security.